Jiangxi Boye Pharmaceutical Technology Co., Ltd. is a subsidiary of Wuhan Boye Technology Development Co., Ltd., which mainly produces and manages chemical intermediates and chemical raw materials. It is a new type of chemical enterprise integrating scientific research, cooperative production and sales. Main products: main products:2- amino-5- sulfhydryl group-One, three, four- thiadiazole CAS :2349-67-9 ;4- chloromethyl benzyl alcohol CAS :16473-35-1 ; m-chloroperoxybenzoic acid CAS :937-14-4 ; m-chlorobenzoic acid535-80-8 (high quality) etc other business of the company: one-time import of reference preparations, transfer of synthesis process, custom synthesis. Company philosophy: focus on drug research and development and production to provide quality services.
more >
Year of Establishment:
2018
Total Number of Staff:
20~29
Main Competitive Advantages:
Brand,Experienced R&D personnel,Delivery speed,Production capacity,Rich product line,Accept small orders,Good reputation,High-quality service
Other Competitive Advantages:
Product innovation is differentiated. We are willing to try difficult products and provide customers with more professional supporting services; long-term and stable cooperation with third-party professional testing agencies to ensure product quality; deep cultivation in the field of fine chemicals for 20 years, honest service is our purpose.
Patents and Copyrights:
Business Type:
Manufacturer,Agent,Trading Company
R&D capacity:
Annual Turnover(USD):
9,000,000~9,999,999
Main Sales Markets:
Asia
Advantage Description: